Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,265
archived clinical trials in
Crohns Disease

B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Gastroenterology Associates of Western Michigan
mi
from
Wyoming, MI
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Gastroenterology Associates of Western Michigan
mi
from
Wyoming, MI
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Metro Health Hospital
mi
from
Wyoming, MI
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Metro Health Hospital
mi
from
Wyoming, MI
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
New York Presbyterian Hospital - Weill Cornell Medical College Investigational Pharmacy
mi
from
New York, NY
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
New York Presbyterian Hospital - Weill Cornell Medical College Investigational Pharmacy
mi
from
New York, NY
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Weill Cornell Imaging at New York Presbyterian Hospital
mi
from
New York, NY
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Weill Cornell Imaging at New York Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Weill Cornell Medical College of Cornell University-Greenberg
mi
from
New York, NY
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Weill Cornell Medical College of Cornell University-Greenberg
mi
from
New York, NY
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Weill Cornell Medical College of Cornell University
mi
from
New York, NY
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Weill Cornell Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Colonoscopy and X-rays: OU Physicians Building
mi
from
Oklahoma City, OK
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Colonoscopy and X-rays: OU Physicians Building
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Oklahoma Foundation for Digestive Research
mi
from
Oklahoma City, OK
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Oklahoma Foundation for Digestive Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Pharmacy: Wheeler and Stuckey, Inc.
mi
from
Oklahoma, OK
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Pharmacy: Wheeler and Stuckey, Inc.
mi
from
Oklahoma, OK
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Hillcrest Medical Center
mi
from
Tulsa, OK
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Hillcrest Medical Center
mi
from
Tulsa, OK
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Options Health Research
mi
from
Tulsa, OK
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Options Health Research
mi
from
Tulsa, OK
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Pittsburgh Gastroenterology Associates
mi
from
Pittsburgh, PA
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Pittsburgh Gastroenterology Associates
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Research Protocol Management Specialists
mi
from
Pittsburgh, PA
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Research Protocol Management Specialists
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Gastro One
mi
from
Germantown, TN
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Gastro One
mi
from
Germantown, TN
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Vanderbilt University Medical Center-GI Research
mi
from
Nashville, TN
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Vanderbilt University Medical Center-GI Research
mi
from
Nashville, TN
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Vanderbilt University Medical Center-IDS
mi
from
Nashville, TN
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Vanderbilt University Medical Center-IDS
mi
from
Nashville, TN
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Austin Gastroenterology, PA
mi
from
Austin, TX
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Austin Gastroenterology, PA
mi
from
Austin, TX
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Professional Quality Research, Inc.
mi
from
Austin, TX
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Professional Quality Research, Inc.
mi
from
Austin, TX
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Diagnostic Clinic of Houston
mi
from
Houston, TX
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Diagnostic Clinic of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
University of Texas Health Science Center at Houston
mi
from
Houston, TX
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Texas Digestive Disease Consultants
mi
from
Southlake, TX
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Texas Digestive Disease Consultants
mi
from
Southlake, TX
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Clinical Pathologiy Laboratories, Inc, DBA DRL Labs
mi
from
Tyler, TX
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Clinical Pathologiy Laboratories, Inc, DBA DRL Labs
mi
from
Tyler, TX
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Digestive Health Specialists of Tyler
mi
from
Tyler, TX
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Digestive Health Specialists of Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
University Of Utah Hospital
mi
from
Salt Lake City, UT
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
University Of Utah Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
VC Medical Center Investigative Drug Service (IDS) [Ship Drug To]
mi
from
Richmond, VA
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
VC Medical Center Investigative Drug Service (IDS) [Ship Drug To]
mi
from
Richmond, VA
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
U of L Health Care Outpatient Center
mi
from
Louisville, KY
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
U of L Health Care Outpatient Center
mi
from
Louisville, KY
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Metro Health Hospital Endoscopy Unit
mi
from
Wyoming, MI
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Metro Health Hospital Endoscopy Unit
mi
from
Wyoming, MI
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Huron Gastroenterology Associates
mi
from
Ypsilanti, MI
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Huron Gastroenterology Associates
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Present, Chapman, Steinlauf and Marion
mi
from
New York, NY
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Present, Chapman, Steinlauf and Marion
mi
from
New York, NY
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Mount Sinai School of Medicine
mi
from
New York, NY
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Arthur Asher Kombluth, MD PC
mi
from
New York, NY
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Arthur Asher Kombluth, MD PC
mi
from
New York, NY
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Vanderbilt University Medical Center-IBD center
mi
from
Nashville, TN
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Vanderbilt University Medical Center-IBD center
mi
from
Nashville, TN
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Virginia Commonwealth University, Clinical Research Services (CRSU)
mi
from
Richmond, VA
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Virginia Commonwealth University, Clinical Research Services (CRSU)
mi
from
Richmond, VA
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Concord Repatriation General Hospital
mi
from
Concord,
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Concord Repatriation General Hospital
mi
from
Concord,
Click here to add this to my saved trials
Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel
Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel
Status: Enrolling
Updated:  1/20/2016
The Mayo Clinic
mi
from
Rochester, MN
Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel
Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel
Status: Enrolling
Updated: 1/20/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease
Phase I Evaluation of Urinary Isoprostane Levels in Pediatric Patients With Inflammatory and Non-Inflammatory Gastrointestinal Disease
Status: Enrolling
Updated:  1/26/2016
Children's Hospital
mi
from
Boston, MA
Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease
Phase I Evaluation of Urinary Isoprostane Levels in Pediatric Patients With Inflammatory and Non-Inflammatory Gastrointestinal Disease
Status: Enrolling
Updated: 1/26/2016
Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
OTIS Autoimmune Diseases in Pregnancy Project
Humira (Adalimumab) Pregnancy Exposure Registry: OTIS Rheumatoid Arthritis in Pregnancy Project
Status: Enrolling
Updated:  1/26/2016
The University of California, San Diego
mi
from
La Jolla, CA
OTIS Autoimmune Diseases in Pregnancy Project
Humira (Adalimumab) Pregnancy Exposure Registry: OTIS Rheumatoid Arthritis in Pregnancy Project
Status: Enrolling
Updated: 1/26/2016
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB Treatment
EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB Treatment
Status: Enrolling
Updated:  2/17/2016
Baylor College of Medicine
mi
from
Houston, TX
EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB Treatment
EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB Treatment
Status: Enrolling
Updated: 2/17/2016
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
Yale University
mi
from
New Haven, CT
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
The Feinstein Institute for Medical Research
mi
from
Manhasset, NY
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
The Feinstein Institute for Medical Research
mi
from
Manhasset, NY
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
University of Rochester
mi
from
Rochester, NY
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
Oklahoma Medical Research Foundation
mi
from
Oklahoma City, OK
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
Oklahoma Medical Research Foundation
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
Baylor Institute of Immunology Research - Clinical Rheumatology
mi
from
Dallas, TX
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
Baylor Institute of Immunology Research - Clinical Rheumatology
mi
from
Dallas, TX
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
Emory University
mi
from
Atlanta, GA
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Anal Human Papillomavirus in Inflammatory Bowel Disease Study
Characterization of Anal Human Papillomavirus (HPV) Infection in the University of Pittsburgh Inflammatory Bowel Disease (IBD) Cohort Study
Status: Enrolling
Updated:  3/9/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Anal Human Papillomavirus in Inflammatory Bowel Disease Study
Characterization of Anal Human Papillomavirus (HPV) Infection in the University of Pittsburgh Inflammatory Bowel Disease (IBD) Cohort Study
Status: Enrolling
Updated: 3/9/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Fecal Microbiota Transplantation in Pediatric Patients
A Study of Fecal Microbiota Transplantation in Pediatric Patients With Relapsed Inflammatory Bowel Disease.
Status: Enrolling
Updated:  4/1/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Fecal Microbiota Transplantation in Pediatric Patients
A Study of Fecal Microbiota Transplantation in Pediatric Patients With Relapsed Inflammatory Bowel Disease.
Status: Enrolling
Updated: 4/1/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Crohn's Disease Diet to Reduce Symptoms of Crohn's Disease
The Relationship of a "Crohn's Disease Diet" in Reducing Symptoms of Crohn's Disease, Improving Quality of Life, and Decreasing Related Health Care Costs.
Status: Enrolling
Updated:  4/4/2016
Johns Hopkins University
mi
from
Baltimore, MD
A Crohn's Disease Diet to Reduce Symptoms of Crohn's Disease
The Relationship of a "Crohn's Disease Diet" in Reducing Symptoms of Crohn's Disease, Improving Quality of Life, and Decreasing Related Health Care Costs.
Status: Enrolling
Updated: 4/4/2016
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Autologous Hematopoietic Stem Cell Transplantation for Crohn's Disease Treatment
Autologous Hematopoietic Stem Cell Transplantation for Crohn's Disease Treatment
Status: Enrolling
Updated:  4/13/2016
UCLA Center for Inflammatory Bowel Diseases
mi
from
Los Angeles, CA
Autologous Hematopoietic Stem Cell Transplantation for Crohn's Disease Treatment
Autologous Hematopoietic Stem Cell Transplantation for Crohn's Disease Treatment
Status: Enrolling
Updated: 4/13/2016
UCLA Center for Inflammatory Bowel Diseases
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluation of Health Costs and Resource Utilization
A Randomized Evaluation of Health Costs and Resource Utilization Comparing Testing-Based Therapy to Empiric Dose Intensification for the Management of Inflammatory Bowel Disease.
Status: Enrolling
Updated:  5/12/2016
Rocky Mountain Gastroenterology Associates
mi
from
Denver, CO
Evaluation of Health Costs and Resource Utilization
A Randomized Evaluation of Health Costs and Resource Utilization Comparing Testing-Based Therapy to Empiric Dose Intensification for the Management of Inflammatory Bowel Disease.
Status: Enrolling
Updated: 5/12/2016
Rocky Mountain Gastroenterology Associates
mi
from
Denver, CO
Click here to add this to my saved trials
Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Crohn's Disease
A Multicenter, Open-Label, Study of Extracorporeal Photoimmune Therapy With UVADEX in the Treatment of Patients With Moderately Active Crohn's Disease Who Are Refractory or Intolerant to Immunosuppressants and/or Anti-TNF Agents
Status: Enrolling
Updated:  5/23/2016
NIH
mi
from
Bethesda, MD
Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Crohn's Disease
A Multicenter, Open-Label, Study of Extracorporeal Photoimmune Therapy With UVADEX in the Treatment of Patients With Moderately Active Crohn's Disease Who Are Refractory or Intolerant to Immunosuppressants and/or Anti-TNF Agents
Status: Enrolling
Updated: 5/23/2016
NIH
mi
from
Bethesda, MD
Click here to add this to my saved trials